PRISM BioLab's Series C Round

PRISM BioLab raised a round of funding on May 27, 2013.

PRISM BioLab is a Japanese drug discovery company focused on developing small molecule technologies that modulate protein-protein interactions. The company has developed a platform technology to modul…

Articles about PRISM BioLab's Series C Round: